A comprehensive genomic analysis of glioblastoma tumors reveals matrisome enrichment associated with mesenchymal phenotypes and pro-tumor immune signatures, a matrisome-based classification of GBM patients, and a prognostic 17-gene matrisome signature.
- Monika Vishnoi
- Zeynep Dereli
- Anil Korkut